(VIANEWS) – OneSpaWorld Holdings Limited (OSW), Lantheus Holdings (LNTH), Amalgamated Bank (AMAL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OneSpaWorld Holdings Limited (OSW)
34.8% sales growth and 16.12% return on equity
OneSpaWorld Holdings Limited operates health and wellness centers onboard cruise ships and at destination resorts worldwide. Its health and wellness centers offer services, such as traditional body, salon, and skin care services and products; self-service fitness facilities, specialized fitness classes, and personal fitness training; pain management, detoxifying programs, and body composition analyses; weight management programs and products; and medi-spa services. The company also provides its guests access to beauty and wellness brands, including ELEMIS, Kérastase, and Dysport, with various brands offered exclusively in the cruise market. As of March 3, 2021, it offered health, wellness, fitness, and beauty services, treatments, and products onboard 159 cruise ships and at 53 destination resorts. The company is based in Nassau, Bahamas.
Earnings Per Share
As for profitability, OneSpaWorld Holdings Limited has a trailing twelve months EPS of $0.5.
PE Ratio
OneSpaWorld Holdings Limited has a trailing twelve months price to earnings ratio of 22.94. Meaning, the purchaser of the share is investing $22.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.12%.
Yearly Top and Bottom Value
OneSpaWorld Holdings Limited’s stock is valued at $11.47 at 11:22 EST, way under its 52-week high of $12.77 and way higher than its 52-week low of $6.80.
Earnings Before Interest, Taxes, Depreciation, and Amortization
OneSpaWorld Holdings Limited’s EBITDA is 2.27.
Moving Average
OneSpaWorld Holdings Limited’s worth is higher than its 50-day moving average of $10.98 and way above its 200-day moving average of $9.37.
Sales Growth
OneSpaWorld Holdings Limited’s sales growth is 97.3% for the current quarter and 34.8% for the next.
2. Lantheus Holdings (LNTH)
27.4% sales growth and 6.16% return on equity
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; and RELISTOR for opioid-induced constipation. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical. It provides Thallium-201 to detect cardiovascular disease; Gallium-67 to detect various infections and cancerous tumors; and Quadramet for severe bone pain associated with osteoblastic metastatic bone lesions. The company also develops PyL for prostate cancer; flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroendocrine tumors; PSMA TTC, a thorium-227 labeled PSMA-targeted antibody therapeutic; 1404, a Tc-99m labeled small molecule; PSMA-AI, an AI-based imaging analysis technology; and leronlimab, an investigational humanized monoclonal antibody. It serves radiopharmacies, PET manufacturing facilities, integrated delivery networks, hospitals, clinics, and group practices. The company has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM Toyama Chemical Co. Ltd.; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Earnings Per Share
As for profitability, Lantheus Holdings has a trailing twelve months EPS of $0.41.
PE Ratio
Lantheus Holdings has a trailing twelve months price to earnings ratio of 194.2. Meaning, the purchaser of the share is investing $194.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.
Volume
Today’s last reported volume for Lantheus Holdings is 922727 which is 10.46% below its average volume of 1030610.
Previous days news about Lantheus Holdings(LNTH)
- According to Zacks on Monday, 3 April, "B – Free Report) , Riley Exploration Permian Inc. (REPX Quick QuoteREPX – Free Report) , Harrow Health Inc. (HROW Quick QuoteHROW – Free Report) and Lantheus Holdings Inc. (LNTH Quick QuoteLNTH – Free Report) ."
- According to Zacks on Tuesday, 4 April, "B – Free Report) , Riley Exploration Permian Inc. (REPX Quick QuoteREPX – Free Report) , Harrow Health Inc. (HROW Quick QuoteHROW – Free Report) and Lantheus Holdings Inc. (LNTH Quick QuoteLNTH – Free Report) .", "These companies are - Bellerophon Therapeutics Inc., Crawford & Co., Riley Exploration Permian Inc., Harrow Health Inc. and Lantheus Holdings Inc."
- According to Zacks on Tuesday, 4 April, "Chicago, IL - April 4, 2023 - Stocks in this week’s article are Lantheus Holdings (LNTH Quick QuoteLNTH – Free Report) , Perion Network (PERI Quick QuotePERI – Free Report) , Alliance Resource Partners (ARLP Quick QuoteARLP – Free Report) and Sea Limited (SE Quick QuoteSE – Free Report) ."
3. Amalgamated Bank (AMAL)
13.6% sales growth and 15.19% return on equity
Amalgamated Financial Corp. operates as a bank holding company for Amalgamated Bank that provides commercial banking and trust services for commercial and retail customers in the United States. The company accepts various deposit products, including non-interest and interest-bearing demand accounts, savings and money market accounts, NOW accounts, and certificates of deposit. It also provides various commercial loans comprising commercial and industrial, multifamily mortgage, and commercial real estate loans; and retail loans, such as residential real estate, and consumer and other loans. In addition, the company offers online banking, bill payment, online cash management, and safe deposit box rental services; debit, prepaid, and ATM cards; and trust, custody, and investment management services comprising asset safekeeping, corporate actions, income collections, proxy, account transition, asset transfers, and conversion management services. Further, it provides investment products, such as equity, fixed-income, real estate, and alternative investment products; and brokerage, asset management, and insurance products. It serves advocacy-based non-profits, social welfare organizations, labor unions, political organizations, foundations, sustainability-focused, socially responsible businesses, and other for-profit companies, as well as their members and stakeholders. The company operates a network of six branches in New York City, Washington D.C., San Francisco, and Boston; and a digital banking and mobile platform. Amalgamated Financial Corp. was founded in 1923 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Amalgamated Bank has a trailing twelve months EPS of $1.57.
PE Ratio
Amalgamated Bank has a trailing twelve months price to earnings ratio of 11.94. Meaning, the purchaser of the share is investing $11.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.19%.
4. Unifirst Corporation (UNF)
10.3% sales growth and 5.4% return on equity
UniFirst Corporation provides workplace uniforms and protective work wear clothing in the United States, Europe, and Canada. The company operates through U.S. and Canadian Rental and Cleaning, Manufacturing, Specialty Garments Rental and Cleaning, and First Aid segments. It designs, manufactures, personalizes, rents, cleans, delivers, and sells a range of uniforms and protective clothing, including shirts, pants, jackets, coveralls, lab coats, smocks, and aprons; and specialized protective wear, such as flame resistant and high visibility garments. The company also rents and sells industrial wiping products, floor mats, facility service products, and dry and wet mops; restroom and cleaning supplies comprising air fresheners, paper products, gloves, masks, sanitizers, and hand soaps; and other textile products. In addition, it provides first aid cabinet services and other safety supplies; decontaminates and cleans work clothes, and other items that is exposed to radioactive materials; and services special cleanroom protective wear and facilities. Further, it offers a range of garment service options, including full-service rental programs in which garments are cleaned and serviced; lease programs in which garments are cleaned and maintained by individual employees; and purchase programs to buy garments and related items directly. The company serves automobile service centers and dealers, delivery services, food and general merchandise retailers, food processors and service operations, light manufacturers, maintenance facilities, restaurants, service companies, soft and durable goods wholesalers, transportation companies, healthcare providers, government agencies, research and development laboratories, high technology companies, and utilities operating nuclear reactors, as well as others who require employee clothing for image, identification, protection, or utility purposes. UniFirst Corporation was founded in 1936 and is headquartered in Wilmington, Massachusetts.
Earnings Per Share
As for profitability, Unifirst Corporation has a trailing twelve months EPS of $5.47.
PE Ratio
Unifirst Corporation has a trailing twelve months price to earnings ratio of 32.22. Meaning, the purchaser of the share is investing $32.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.4%.
Volume
Today’s last reported volume for Unifirst Corporation is 136646 which is 70.58% above its average volume of 80104.
5. Boston Scientific (BSX)
6% sales growth and 4.07% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.45.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 65.24. Meaning, the purchaser of the share is investing $65.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.07%.
Volume
Today’s last reported volume for Boston Scientific is 1790360 which is 77.28% below its average volume of 7880370.
Moving Average
Boston Scientific’s value is above its 50-day moving average of $47.40 and way higher than its 200-day moving average of $43.12.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 12.68B for the twelve trailing months.
Sales Growth
Boston Scientific’s sales growth is 4.3% for the ongoing quarter and 6% for the next.
